Clinical Trial Update: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom [Phase 3]

View source ↗

Summary

Phase 3 trial assessing immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine in infants and toddlers when given with routine pediatric va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infection

Drugs mentioned

• Quadrivalent meningococcal conjugate vaccine (meningococcal conjugate vaccine quadrivalent (MenACWY))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Healthy Volunteers (Meningococcal Infection) | Phase 3 | Status: COMPLETED | Results posted: 2023-11-07